• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于超声技术与磁共振成像质子密度脂肪分数在测量肝脂肪变性患儿肝脏脂肪含量中的比较

Comparison of Ultrasound-Based Techniques and Magnetic Resonance Imaging Proton Density Fat Fraction in Measuring the Amount of Hepatic Fat in Children with Hepatosteatosis.

作者信息

Bozbeyoglu Sabriye Gulcin, Asik Murat

机构信息

Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Clinic of Radiology, Istanbul, Türkiye.

出版信息

Medeni Med J. 2025 Jun 26;40(2):46-52. doi: 10.4274/MMJ.galenos.2025.34017.

DOI:10.4274/MMJ.galenos.2025.34017
PMID:40569781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12203445/
Abstract

OBJECTIVE

The aim of this study is to demonstrate the reliability of Quantitative Ultrasound (QUS) in assessing liver fat content in children, using magnetic resonance imaging proton density fat fraction (MRI-PDFF) values as a reference, and to determine threshold values for QUS in grading hepatosteatosis.

METHODS

The study group consisted of pediatric patients under 18 years of age without known liver disease who volunteered to participate. All patients underwent MRI-PDFF scanning, and QUS imaging was performed using the tissue attenuation imaging (TAI) ve tissue scatter distribution imaging (TSI) tools. The cut-off values for MRI-PDFF were set at ≥5%, ≥16.3%, and ≥21.7%, corresponding to mild, moderate, and severe steatosis, respectively. The diagnostic performance of TAI and TSI in detecting various degrees of hepatic steatosis was evaluated using the area under the ROC (AUROC) curves.

RESULTS

The frequencies of hepatosteatosis grading were as follows: S1: 19 (37%), S2: 5 (10%), S3: 22 (43%). The AUROCs for TAI and TSI tools in detecting QUS measurements (MRI PDFF ≥5%) were 0.95 [95% confidence interval (CI): 0.91-0.99] (p< 0.001) and 0.96 (95% CI: 0.93-0.99) (p<0.001), respectively. For distinguishing different degrees of steatosis, TAI showed values of 0.75, 0.86, and 0.96 dB/cm/MHz, corresponding to sensitivities of 88%, 88%, and 100%, respectively, while TSI showed values of 92.44, 96.64, and 99.45, with sensitivities of 90%, 92%, and 91.7%. The correlation test between QUS measurements [TAI, TSI, EzHRI (Hepato-Renal Index with Automated regions of interest Recommendation)] and MR-PDFF indicated a concordance in TAI and TSI values, but not with EzHR.

CONCLUSIONS

The TAI and TSI tools can accurately measure liver fat content and can be used reliably in children for the assessment and grading of hepatosteatosis.

摘要

目的

本研究旨在以磁共振成像质子密度脂肪分数(MRI-PDFF)值为参照,论证定量超声(QUS)评估儿童肝脏脂肪含量的可靠性,并确定QUS对肝脂肪变性进行分级的阈值。

方法

研究组由18岁以下无已知肝脏疾病且自愿参与的儿科患者组成。所有患者均接受了MRI-PDFF扫描,并使用组织衰减成像(TAI)和组织散射分布成像(TSI)工具进行QUS成像。MRI-PDFF的临界值分别设定为≥5%、≥16.3%和≥21.7%,分别对应轻度、中度和重度脂肪变性。使用ROC曲线下面积(AUROC)评估TAI和TSI检测不同程度肝脂肪变性的诊断性能。

结果

肝脂肪变性分级的频率如下:S1:19例(37%),S2:5例(10%),S3:22例(43%)。TAI和TSI工具检测QUS测量值(MRI PDFF≥5%)的AUROC分别为0.95 [95%置信区间(CI):0.91-0.99](p<0.001)和0.96(95%CI:0.93-0.99)(p<0.001)。为区分不同程度的脂肪变性,TAI显示的值为0.75、0.86和0.96 dB/cm/MHz,对应的敏感度分别为88%、88%和100%,而TSI显示的值为92.44、96.64和99.45,敏感度分别为90%、92%和91.7%。QUS测量值[TAI、TSI、EzHRI(带自动感兴趣区域推荐的肝肾指数)]与MR-PDFF之间的相关性测试表明,TAI和TSI值具有一致性,但与EzHR不一致。

结论

TAI和TSI工具可准确测量肝脏脂肪含量,可可靠地用于儿童肝脂肪变性的评估和分级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/12203445/66fec7ff48cb/MedeniMedJ-40-2-46-figure-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/12203445/9db0dba14c09/MedeniMedJ-40-2-46-figure-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/12203445/89aaf85563a6/MedeniMedJ-40-2-46-figure-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/12203445/66fec7ff48cb/MedeniMedJ-40-2-46-figure-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/12203445/9db0dba14c09/MedeniMedJ-40-2-46-figure-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/12203445/89aaf85563a6/MedeniMedJ-40-2-46-figure-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/12203445/66fec7ff48cb/MedeniMedJ-40-2-46-figure-3.jpg

相似文献

1
Comparison of Ultrasound-Based Techniques and Magnetic Resonance Imaging Proton Density Fat Fraction in Measuring the Amount of Hepatic Fat in Children with Hepatosteatosis.基于超声技术与磁共振成像质子密度脂肪分数在测量肝脂肪变性患儿肝脏脂肪含量中的比较
Medeni Med J. 2025 Jun 26;40(2):46-52. doi: 10.4274/MMJ.galenos.2025.34017.
2
Hepatic Fat Quantification With Novel Ultrasound Based Techniques: A Diagnostic Performance Study Using Magnetic Resonance Imaging Proton Density Fat Fraction as Reference Standard.基于新型超声技术的肝脏脂肪定量:以磁共振成像质子密度脂肪分数为参考标准的诊断性能研究
Can Assoc Radiol J. 2023 May;74(2):362-369. doi: 10.1177/08465371221123696. Epub 2022 Sep 13.
3
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter study.以基于磁共振成像的质子密度脂肪分数为参考标准,比较衰减成像与受控衰减参数对肝脂肪变性的诊断性能:一项前瞻性多中心研究。
J Gastroenterol. 2025 Jun;60(6):727-737. doi: 10.1007/s00535-025-02224-0. Epub 2025 Feb 24.
4
Ultrasound hepatorenal index for the diagnosis of steatosis in patients with type 2 diabetes: a prospective validation study.超声肝肾指数用于诊断2型糖尿病患者肝脂肪变性:一项前瞻性验证研究。
Eur Radiol. 2025 Jun 25. doi: 10.1007/s00330-025-11774-z.
5
Quantitative ultrasound fatty liver evaluation in a pediatric population: comparison with magnetic resonance imaging of liver proton density fat fraction.小儿人群定量超声脂肪肝评估:与肝脏质子密度脂肪分数磁共振成像的比较。
Pediatr Radiol. 2023 Nov;53(12):2458-2465. doi: 10.1007/s00247-023-05749-9. Epub 2023 Sep 12.
6
Attenuation Coefficient for Hepatic Steatosis Using a Single Ultrasound System: Associations of Measurement Parameters With Interoperator Agreement and Diagnostic Performance.使用单一超声系统测量肝脂肪变性的衰减系数:测量参数与不同操作者间一致性及诊断性能的关联
AJR Am J Roentgenol. 2025 Jun;224(6):e2532746. doi: 10.2214/AJR.25.32746. Epub 2025 Jun 25.
7
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
8
Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.磁共振成像质子密度脂肪分数作为参考标准的非酒精性脂肪性肝病肝脂肪变性的定量超声射频数据分析。
Korean J Radiol. 2021 Jul;22(7):1077-1086. doi: 10.3348/kjr.2020.1262. Epub 2021 Mar 9.
9
Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.血小板计数、脾脏长度以及血小板计数与脾脏长度之比在慢性肝病或门静脉血栓形成患者食管静脉曲张诊断中的应用
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD008759. doi: 10.1002/14651858.CD008759.pub2.
10
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.磁共振成像在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2.

本文引用的文献

1
A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD.三种基于超声的技术在非酒精性脂肪性肝病肝脂肪变定量诊断中的前瞻性比较。
Abdom Radiol (NY). 2024 Jan;49(1):81-92. doi: 10.1007/s00261-023-04078-7. Epub 2023 Nov 11.
2
Quantitative ultrasound fatty liver evaluation in a pediatric population: comparison with magnetic resonance imaging of liver proton density fat fraction.小儿人群定量超声脂肪肝评估:与肝脏质子密度脂肪分数磁共振成像的比较。
Pediatr Radiol. 2023 Nov;53(12):2458-2465. doi: 10.1007/s00247-023-05749-9. Epub 2023 Sep 12.
3
Two-dimensional Convolutional Neural Network Using Quantitative US for Noninvasive Assessment of Hepatic Steatosis in NAFLD.
使用定量超声的二维卷积神经网络对非酒精性脂肪性肝病(NAFLD)患者肝脂肪变性进行无创评估
Radiology. 2023 Apr;307(1):e221510. doi: 10.1148/radiol.221510. Epub 2023 Jan 3.
4
US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.美国肝脏脂肪定量衰减校正:AIUM-RSNA QIBA 脉冲回波定量超声倡议。
Radiology. 2022 Mar;302(3):495-506. doi: 10.1148/radiol.210736. Epub 2022 Jan 25.
5
Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.非侵入性方法用于成像肝脂肪变性及其在非酒精性脂肪性肝病中的临床重要性。
Nat Rev Endocrinol. 2022 Jan;18(1):55-66. doi: 10.1038/s41574-021-00584-0. Epub 2021 Nov 23.
6
Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method.超声引导衰减参数(UGAP)用于定量肝脂肪变性,以受控衰减参数(CAP)作为参考方法。
Med Ultrason. 2021 Feb 18;23(1):7-14. doi: 10.11152/mu-2688. Epub 2020 Oct 8.
7
Novel Method for Ultrasound-Derived Fat Fraction Using an Integrated Phantom.一种使用集成体模进行超声脂肪分数测量的新方法。
J Ultrasound Med. 2020 Dec;39(12):2427-2438. doi: 10.1002/jum.15364. Epub 2020 Jun 11.
8
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD:代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
9
Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort.超声定量评估肝脂肪变:衰减系数成像在经肝活检证实的队列中具有良好的应用前景。
Eur Radiol. 2020 Apr;30(4):2293-2301. doi: 10.1007/s00330-019-06480-6. Epub 2019 Dec 10.
10
Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique.应用衰减成像评估肝脂肪变:一种定量、易于操作的超声技术。
Eur Radiol. 2019 Dec;29(12):6499-6507. doi: 10.1007/s00330-019-06272-y. Epub 2019 Jun 7.